{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:27:15Z","timestamp":1754152035563,"version":"3.41.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.medcli.2025.107044","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:38:01Z","timestamp":1749724681000},"page":"107044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Controversias en la nomenclatura: de la esteatohepatitis no alcoh\u00f3lica al espectro completo de la esteatosis hep\u00e1tica"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-8947","authenticated-orcid":false,"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.107044_bib0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0205","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0210","first-page":"161","article-title":"Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hep\u00e1tica metab\u00f3lica (EHmet)","volume":"113","author":"Romero-G\u00f3mez","year":"2021","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.medcli.2025.107044_bib0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.medcli.2025.107044_bib0220","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0225","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.jhep.2023.09.038","article-title":"From NAFLD to MASLD: Promise and pitfalls of a new definition","volume":"81","author":"Cusi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0230","unstructured":"Alboraie M, Fouad Y, Eslam M. Letter to the Editor: MAFLD versus MASLD\u2013Which is more appropriate from a global perspective? Hepatology [consultado 18 Nov 2024]. Disponible en: https:\/\/journals.lww.com\/hep\/fulltext\/9900\/letter_to_the_editor__mafld_versus_masld_which_is.874.aspx"},{"key":"10.1016\/j.medcli.2025.107044_bib0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","article-title":"Breaking new ground: MASLD vs. MAFLD\u2014which holds the key for risk stratification?","volume":"18","author":"Ram\u00edrez-Mej\u00eda","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.medcli.2025.107044_bib0240","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.medcli.2022.06.017","article-title":"Non-alcoholic steatohepatitis [Article in English, Spanish]","volume":"159","author":"Romero-G\u00f3mez","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2025.107044_bib0245","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2025.107044_bib0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.medcli.2025.107044_bib0255","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.medcli.2025.107044_bib0260","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.medcli.2025.107044_bib0265","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep4.1199","article-title":"Association of Hepatic Steatosis With Subclinical Atherosclerosis: Systematic Review and Meta-Analysis","volume":"2","author":"Kapuria","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.medcli.2025.107044_bib0270","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.medcli.2025.107044_bib0275","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.medcli.2025.107044_bib0280","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.medcli.2025.107044_bib0290","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"Staufer","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0295","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0300","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.aprim.2011.02.012","article-title":"Prevalence alcohol consumption and cardiovascular risk factors in an Extremadura health area. Hermex study [Article in Spanish]","volume":"44","author":"F\u00e9lix-Redondo","year":"2012","journal-title":"Aten Primaria"},{"key":"10.1016\/j.medcli.2025.107044_bib0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0044-1785228","article-title":"Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?","volume":"44","author":"Romero-G\u00f3mez","year":"2024","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.medcli.2025.107044_bib0315","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jhep.2023.07.017","article-title":"Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD","volume":"80","author":"Ratziu","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0320","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/liv.15695","article-title":"Exploring the landscape of steatotic liver disease in the general US population","volume":"43","author":"Ciardullo","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.medcli.2025.107044_bib0325","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/HEP.0000000000000664","article-title":"Prevalence, distribution and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings","volume":"79","author":"Lee","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.medcli.2025.107044_bib0330","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/jcm13041158","article-title":"Prevalence of steatotic liver disease based on a new nomenclature in the Japanese population: A health checkup-based cross-sectional study","volume":"13","author":"Miwa","year":"2024","journal-title":"JK Clin Med"},{"key":"10.1016\/j.medcli.2025.107044_bib0335","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/liv.15695","article-title":"Exploring the landscape of steatotic liver disease in the general US population","volume":"43","author":"Ciardullo","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.medcli.2025.107044_bib0340","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms25105203","article-title":"Drug-induced fatty liver disease (DIFLD): A comprehensive analysis of clinical, biochemical and histopathological data for mechanisms identification and consistency with current adverse outcome pathways","volume":"25","author":"Lopez-Pascual","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2025.107044_bib0345","first-page":"287","article-title":"Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficency (LAL-C). Clinical and diagnostic aspects, and a new treatment. An update","volume":"115","author":"Bay","year":"2017","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.medcli.2025.107044_bib0350","first-page":"256","article-title":"Hepatic steatosis associated with heterozygotic familial hypobetalipoproteinemia","volume":"27","author":"Alapont-Puchalt","year":"2004","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0355","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2015.01.034","article-title":"Hepatic steatosis in Wilson disease: Role of copper and PNPLA3 mutations","volume":"63","author":"Stattermayer","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0360","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5223\/pghn.2021.24.6.518","article-title":"Distinctive features of hepatic steatosis in children: Is it primary or secondary to inborn errors of metabolism?","volume":"24","author":"Nur Karhan","year":"2021","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.medcli.2025.107044_bib0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvh.12035","article-title":"Hepatitis C virus diversity and hepatic steatosis","volume":"20","author":"Roingeard","year":"2013","journal-title":"J Vir Hepat"},{"key":"10.1016\/j.medcli.2025.107044_bib0370","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jhep.2015.01.013","article-title":"Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease","volume":"62","author":"Reilly","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2025.107044_bib0375","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cld.2023.01.011","article-title":"Special population: Lean non-alcoholic fatty liver disease","volume":"27","author":"Duseja","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.medcli.2025.107044_bib0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/PTT.S141629","article-title":"Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: Utility of transient elastography","volume":"8","author":"Cheng","year":"2018","journal-title":"Psoriasis"},{"key":"10.1016\/j.medcli.2025.107044_bib0385","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/hep4.2008","article-title":"Tamoxifen use and potential effects on liver parenchyma: A long term prospective transient elastographic evaluation","volume":"6","author":"Louwrens Braal","year":"2022","journal-title":"Hepatol Commun"},{"journal-title":"J Hepatol","year":"2024","key":"10.1016\/j.medcli.2025.107044_bib0390"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325002726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325002726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:43:40Z","timestamp":1753101820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325002726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0025775325002726"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107044","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversias en la nomenclatura: de la esteatohepatitis no alcoh\u00f3lica al espectro completo de la esteatosis hep\u00e1tica","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107044"}}